Strong buy Accuracy in direction.Accuracy in direction. I started with penny stocks then forex. Through it all I stuck with reading the charts and understanding it. I've used tradeview as a diary for myself.
0%
0%
0%
0%
0%
About Repligen Corporation
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Tony J. Hunt
Website
repligen.com
Headquarters
Waltham
Employees
2.025K
Founded
1981
ISIN
US7599161095
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
A lot of check blocks hit for RGENRGEN - Shorter swing trade with a tight stop @ the 8 EMA; Nice consolidation with 8 & 21 EMA; above the 200 MA. Nice Earnings history; nice FIB pullback and some good risk/reward.
RGEN Ready to ReboundAssalamualaikum and greeting. Below my expectation of this stock company
Technical
1. Price on Uptrend and go for retrace
2. Price now hit EMA 200 and expected to rebound
3. The setup of Bullish Divergence clearly seen in MACD Indicator
4. MACD signal had give crossover
5. Volume is nice
Fundamen
$RGEN 2 Months Into Its Base with CANCLIM Fundamentals $RGEN 2 months into its base building after a 100% strong run from May bottom.
CANSLIM earnings, sales, growth, group strength and sponsorship.
Base doesn't look complete yet but defiantly one you want to add to your watchlist.
Fantastic breakout on $RGEN - Waiting for a pullback to entryFantastic breakout on $RGEN - Waiting for a pullback to entry
Too overextend at the moment.
RGEN will take a dip in the coming dayRGEN is going to dip if you feel you’re going to take a loss on this stock I would advise selling sooner rather then later.
The chart that I’ve referenced is the Vortex Indicator and from my analysis the lines are going to cross negatively.
So I advise selling while you still have gains on it.
Rem
$RGENEntry price : 188.21
Fundamentals :
- Sector: Medical - Medical Products
- EPS % Chg (Last Qtr): 54%
- EPS % Chg (Previous Qtr): 27%
- 3 Year EPS Growth Rate: 31%
- EPS Est % Chg (Current Yr): 35%
- Sales % Chg (Last Qtr): 35%
- Sales % Chg (Previous Qtr): 24%
- 3-Year Sales Growth Rate: 3
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
